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A	 3-year	 environmental	 and	 clinical	 Vibrio  vulnificus 
survey using simple-sequence repeats typing shows that 
V. vulnificus biotype 3 constitutes ≈21% of the bacterium 
population in tested aquaculture ponds as opposed to ≈86% 
of	clinical	cases.	Simple-sequence	repeats	proved	to	be	a	
useful epidemiologic tool, providing information on the envi-
ronmental source of the pathogen.
V
ibrio vulnificus is a highly invasive human pathogen 
and presents a food safety issue worldwide. Human 
infections caused by V. vulnificus are primarily caused by 
contaminated seafood consumption or contaminated skin 
wounds, which can lead to septicemia, wound infections, 
and high hospitalization and fatality rates (1,2). V. vulnifi-
cus strains are biochemically divided into 3 biotypes (BTs). 
BT3, found in Israel, is associated with infections caused 
by contaminated fish (3). Until now, only 3 BT3 isolates 
had been isolated from the environment in direct contrast 
with their large clinical numbers (3,4).
BT3 is a clonal group, which various molecular methods 
have failed to differentiate among its strains, (4,5) with the 
exceptions of rep-PCR (6), simple-sequence repeats (SSR) 
(7), and recently pulsed-field gel electrophoresis (PFGE) 
(8). SSR analysis of V. vulnificus was highly discriminative 
among BT3 strains (7). These SSR markers have been used 
for typing and for epidemiologic studies in many bacterial 
species (9,10). We present results from a 3-year monitoring 
program of clinical and environmental V. vulnificus using 
SSR as an epidemiologic genotyping tool.
The Study
A total of 414 V. vulnificus isolates were studied, in-
cluding a reference panel of 32 strains previously studied 
(7). A total of 360 environmental V. vulnificus isolates were 
successfully retrieved from September 2004 through Octo-
ber 2006 from artificial fish ponds and stores in the western 
Galilee region of Israel (from 21 samplings), and 22 clini-
cal isolates were retrieved from nearby hospitals during 
matching years (Tables 1, 2). Fish samples were collected 
and gills and fins/scales were pooled from ≈10 Tilapia spp. 
(300–400 g). Each sample was incubated in 0.5 L modified 
alkaline peptone water with 4% NaCl, pH 6.9, at 37oC for 
16 to 18 h. Samples were diluted in saline and streaked 
on thiosulfate-citrate-bile-salts-sucrose (TCBS) agar. Sus-
pected colonies were further grown on chromogenic agar 
(CHROMagar Microbiology, Paris, France), and validated 
by amplification of V. vulnificus–specific gene vvh (7). All 
V. vulnificus colonies were green on TCBS agar. Notably, 
not all bacterial isolates showed the expected turquoise-
colonies on CHROMagar but rather pale white colonies. 
The latter colonies were further identified as BT3. All other 
isolates, which were BT1, showed the expected turquoise-
colony phenotype. No BT2 isolates were found. However, 
6 previously studied isolates (7) showed the expected tur-
quoise-colony.
SSRs were used to genetically characterize 254 clini-
cal and environmental V. vulnificus isolates (Table 1), in-
cluding 32 previously studied isolates (7). DNA extraction, 
PCR and primers, SSR sizing, and statistical analysis were 
conducted as previously described (7). Capillary electro-
phoresis was performed by using a 3130 Genetic Analyzer 
and analyzed with GeneMapper-v4.0 (Applied-Biosystems 
Inc., Foster City, CA, USA). Two to 34 alleles were de-
tected at the 12 SSR loci among the isolates. Environmen-
tal isolates were selected from 21 samples with an average 
8.5 isolates per enrichment. We removed 71 isolates that 
had identical SSR genotypes and originated from the same 
enrichment from the analysis because they were probably 
clones. Thus, 183 isolates were discriminated to 170 SSR 
types. SSR variation data was used to calculate genetic re-
lationships among isolates. A genetic distance matrix was 
generated followed by cluster analysis (7). The resulting 
dendrogram (Figure 1) showed clear separation between 
BT3 isolates and the others (average genetic distance of 
0.825 ± 0.101). Genetic distances among BT3 isolates were 
rather low (average 0.369 ± 0.174) relative to high genetic 
distances (average 0.804 ± 0.149) found among isolates of 
the other biotypes, in accordance with our previous analy-
sis of 32 isolates (7). The new studied isolates showed a 
variety of SSR genotypes and were spread throughout the 
dendrogram (Figure 1). Further analysis using eBURST 
(12) showed similar grouping results (data not shown) (7).
Differentiation of SSR alleles results at locus VV0401 
into environmental types (E-types, >12 repeats), and clini-
cal types (C-types, <10 repeats) was tested (13). Of the 
clinical isolates, 44 isolates (98%) exhibited the expected 
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C-type allele/repeat but only 69 isolates (33%) of the envi-
ronmental isolates showed the E-type allele/repeat, reject-
ing the null hypothesis (p<0.0001), using Pearson χ2 test. 
Notably, 97% of 110 BT3 isolates (clinical/environmental) 
showed the C-type allele/repeat, in contrast to BT1 iso-
lates (72 isolates, 2%). If, C-type allele/repeat at VV0401 
is an indication of potential pathogenicity of V. vulnificus 
strains, then our results further support the high virulence 
of BT3. However, additional studies are needed to confirm 
the relationship of this locus to pathogenicity.
Three  clinical  BT3  isolates  exhibited  identical  SSR 
genotypes and 2 clinical BT3 isolates had a genotype re-
lated to 5 environmental isolates sampled on related dates 
from nearby regional areas (Figure 1, panel B). One clinical 
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Table 1. Vibrio vulnificus isolates from Israel that were	genetically	analyzed,	2003–2006*	
Isolate identification  Biotype Date  Origin/hospital name  IMH	no.†	
Environmental
	 VVyb1 3
	 VVyb2–VVyb58,	(VVyb38,	VVyb45	missing) 1
2004 Store:	yb1-yb53	
Pond:	yb54-yb58
	 VVyb63,	VVyb66,	VVyb67	VVyb71–VVyb73,	VVyb83,	VVyb86–Vvyb93,	
	 VVyb95–Vvyb109,	VVyb111–VVyb126
3
	 VVyb59–VVyb62,	VVyb64,VVyb65,	VVyb68–VVyb70,	VVyb74–VVyb82,	
	 VVyb84,	VVyb85,	VVyb159,	VVyb162–VVyb164,	VVyb167–VVyb170,		
	 VVyb172–VVyb182,	VVyb187,	VVyb189–VVyb193
1
	 VVyb94,	VVyb110,	VVyb158,	VVyb160,	VVyb161,	VVyb165,	VVyb166,	
	 VVyb171,	VVyb183–VVyb186,	VVyb188
ND
2005 Store:	yb87-yb126,	
yb158-yb193	
Pond:	yb62-yb86	
	 VVyb127–Vyb133,	VVyb137–VVyb157 3
	 VVyb134–VVyb136,	VVyb195–VVyb208,	VVyb210–VVyb216,		
	 VVyb218–VVyb221,	(VVyb201,	VVyb212	missing)
1
	 VVyb209,	VVyb217 ND
2006 Store:	yb127-yb134,	
yb194-yb206	
Pond:	yb135-yb157,	
yb207-yb221
	 v232‡ 3 2003 Dec Fish 8/03e
Clinical§
  v233 3 2006 May  Rivka	Ziv 1/06
  v234 3 2006	Sep HaEmek 2/06
	 v235 ND 2006 Oct Western	Galilee 3/06
  v236 3 2005	Feb HaEmek 1/05
  v237 3 2005	Jun	 Western	Galilee 2/05
  v238 3 2005	Jun Western	Galilee 5/05
	 v239 3 2005	Aug Rambam 6/05
  v240 3 2005	Oct Western	Galilee 7/05
  v241 3 2005	Nov Rambam 8/05
  v242 3 2005	Nov Rambam 9/05
  v243 3 2005	Dec Carmel 10/05
  v244 3 2005	Nov Western	Galilee 11/05
	 v245 3 2005	Jun Carmel 3/05
  v246 ND† 2005	Jun Rambam 4/05
  v247 3 2004	Jun HaEmek 2/04
  v248 3 2004	Jun HaEmek 3/04
	 v249 3 2004	Jun	 HaEmek 4/04
	 v250 3 2004	Jul Rambam 5/04
	 v251 3 2004	Aug Western	Galilee 6/04
	 v252 1 2004	Aug Western	Galilee 7/04
	 v253 3 2004 Oct Carmel 9/04
	 v254 3 2003 Dec Barzilai 8/03
*IMH,	Israeli	Ministry	of	Health;	ND,	not	determined.		
†All	clinical	isolates	are	part	of	the	IMH	collection.	
‡Previously	studied	(7). 
§All	clinical	isolates	are	associated	with	fish.	
Table 2. Environmental Vibrio vulnificus isolates obtained in Israel from artificial fish ponds and fish stores, 2004–2006 
Dates No.	samples No.	isolates No. V. vulnificus* Biotype 3, % Biotype 1, %†
2004	Sep–Oct 7 58 58 2 98
2005	May–Oct 5 280 166 28 72
2006 Mar–Oct 9 251 136 21 79
Total 21 589 360
*Tested	by	specific	amplification	of	vvh gene. 
†Including isolates not determined. BT3 isolate v239 (August 2005) showed SSR genotypes 
identical to the environmental isolate VVyb95 obtained in 
the same month (August 2005) and to VVyb194 (obtained 
in March 2006). A second BT3 clinical isolate v240 (Oc-
tober  2005)  and  the  fish-pond  isolate  VVyb132  (March 
2006) had identical SSR genotypes. Moreover, these 2 re-
sults suggest survival of V. vulnificus strains through the 
winter season, either in a viable nonculturable state (14) 
or as viable cells in sediment that can serve as a shelter 
for some subpopulations (15). The latter scenario is more 
probable in artificial fish ponds because water circulation 
is high throughout the growth period and pond sediment 
remains untouched. A third clinical isolate was analyzed 
earlier and showed an epidemiologic connection: v254 iso-
late was obtained from an injured woman (injured by a fish) 
in December 2003. Analysis of microbial flora on the fish 
(found in the woman’s freezer) identified a V. vulnificus 
BT3 isolate, v232. These 2 isolates showed identical SSR 
genotypes, confirming the fish as the origin of infection 
(Figure 1, panel B). Additionally, clinical BT1 isolate v252 
(August 2004), showed similar SSR genotypes, 1 repeat 
difference  in  1  locus,  to  environmental  isolate  VVyb50 
(October 2004).
To strengthen our typing results, we compared the epi-
demiologic SSR results to those of PFGE in 12 representa-
tive BT3 isolates. PFGE was performed and analyzed as 
described previously (8). Results for PFGE were generally 
similar to results for SSR (Figure 2). PFGE patterns were 
similar (>85%) between isolates. Identical PFGE patterns 
and SSR genotypes were seen in isolates v239 (clinical) 
and VVyb95, VVyb194 (environmental), as were isolates 
v232 (fish) and v254 (clinical). Identical PFGE patterns and 
single-locus variants in SSR genotypes were seen in clini-
cal isolate v237 and the environmental isolates VVyb89 
and VVyb1. Notably, VVyb1, which was isolated a year 
earlier, differentiated from VVyb89 by another single re-
peat in an additional single locus, confirming higher resolu-
tion of SSR method. Finally, identical SSR genotypes and 
PFGE patterns that differed by 1 band were seen in v240 
and VVyb132.
Conclusions
The  developed  isolation  and  enrichment  procedures 
obtained large numbers of BT3 and BT1 from the environ-
ment. Results showed that although BT3 makes up only 
≈21% of the V. vulnificus isolates from fish, BT3 accounts 
for ≈86% of the clinical cases and thus could imply high 
pathogenicity for this group (4). Genetic analysis of this 
large  survey  confirms  the  distinctness  (clonality)  (5)  of 
BT3 and the high resolution power of the SSR (7).
SSR genotyping of V. vulnificus was used to determine 
the genetic relatedness between clinical and environmen-
tal isolates and identify the source of contamination. SSR 
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Figure	1.	A)	Genetic	relationships	based	on	simple-sequence	repeat	
(SSR)	variation	data	among	183	Vibrio vulnificus isolates including 
135	new	environmental,	22	new	clinical,	and	26	previously	studied	
isolates.	B)	A	subtree	enlargement	of	panel	A	displaying	a	set	of	65	
V. vulnificus	biotype	3	isolates.	Similar	clinical	and	environmental	
isolates, showing an epidemiologic connection, are indicated by 
arrows. The genetic-distance matrix was generated based on 212 
polymorphic	points	(the	sum	of	alleles	across	12	SSR	loci).	Genetic	
relationships  are  based  on  unweighted  pair  group  method  with 
arithmetic	mean	cluster	analysis	of	SSR	variation	using	MEGA4	
software (11).	Scale	bar	represents	genetic	distance.Vibrio vulnificus Infections
can serve as an epidemiologic tool to indicate the infection 
source of pathogens such as V. vulnificus, and can poten-
tially provide knowledge for preventive steps in terms of 
public health.
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Figure	2.	Genetic	relationships	showing	
the  epidemiologic  connection  among 
12  clinical  and  environmental  Vibrio 
vulnificus  biotype  3  isolates  based 
on	 pulsed-field	 gel	 electrophoresis	
(PFGE)	analysis	compared	to	analysis	
at	 12	 single-sequence	 repeat	 (SSR)	
loci.	PFGE	profiles	were	compared	by	
using	 the	 Dice	 coefficient	 followed	 by	
unweighted  pair  group  method  with 
arithmetic  mean  clustering  (tolerance, 
1.0%).	 Scale	 bars	 represent	 pattern	
similarity	 (%	 for	 PFGE	 and	 genetic	
distance	for	SSR).
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